1. Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes
   Matthew L. Scott et al, 2018, Virology CrossRef
2. Sequential Release of Paclitaxel and Imatinib from Core–Shell Microparticles Prepared by Coaxial Electrospray for Vaginal Therapy of Cervical Cancer
   Zhepeng Liu et al, 2021, International Journal of Molecular Sciences CrossRef
3. Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages
   Eliza Julia Pedraza-Brindis et al, 2016, Cellular Immunology CrossRef
4. Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations
   Katalin Balázs et al, 2022, Cancers CrossRef
5. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis
   Paweł Łaniewski et al, 2019, Scientific Reports CrossRef
6. KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells
   Lu Dai et al, 2017, Oncotarget CrossRef
7. CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space
   Jan Korbecki et al, 2022, International Journal of Molecular Sciences CrossRef
8. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
   Fatemeh Moosavi et al, 2019, Critical Reviews in Clinical Laboratory Sciences CrossRef
9. Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis
   Zulei Zhang et al, 2019, Cancer Biology & Therapy CrossRef
10. Clinical and prognostic value of the C‐Met/HGF signaling pathway in cervical cancer
    Nadia Boromand et al, 2018, Journal of Cellular Physiology CrossRef
11. The prevalence of human herpesvirus 8 in normal, premalignant, and malignant cervical samples of Iranian women
    Sara Chavoshpour-Mamaghani et al, 2021, Virology Journal CrossRef
12. CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure
    Elodie Coquan et al, 2021, BMC Cancer CrossRef
13. HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
    Jianjiang Fu et al, 2021, Oncogene CrossRef
14. Place des thérapies innovantes dans la prise en charge des cancers du col de l’utérus
    Diana Bello Roufai, 2024, Bulletin du Cancer CrossRef